Paper41870545
Montelukast impressively mitigates biomarkers of inflammation in non-ST-segment elevation myocardial infarction patients: a randomized, double-blind, placebo-controlled clinical trial.
Shahri B and 6 others. Naunyn Schmiedebergs Arch Pharmacol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Montelukast impressively mitigates biomarkers of inflammation in non-ST-segment elevation myocardial infarction patients: a randomized, double-blind, placebo-controlled clinical trial. Papers, record 41870545. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41870545
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Montelukast impressively mitigates biomarkers of inflammation in non-ST-segment elevation myocardial infarction patients: a randomized, double-blind, placebo-controlled clinical trial.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Quinolines | Major topic |
| Acetates | Major topic |
| C-Reactive Protein | Major topic |
| Leukotriene Antagonists | Major topic |
| Non-ST Elevated Myocardial Infarction | Major topic |
| Inflammation | Major topic |
| Anti-Inflammatory Agents | Major topic |
| Humans | |
| Cyclopropanes | |
| Double-Blind Method | |
| Sulfides | |
| Male | |
| Female | |
| Biomarkers | |
| Interleukin-6 | |
| Middle Aged | |
| Aged | |
| Treatment Outcome |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26948314 | Involvement of opioid receptors in the systemic and peripheral antinociceptive actions of montelukast in the animal models of pain. | Eur J Pharmacol | 2016 | https://conductscience.org/library/papers/26948314 | PubMed |
| 2 | 40988347 | The Osaka Prognostic Score Predicts All-Cause in-Hospital Mortality in Patients With Non-ST-Elevation Myocardial Infarction Undergoing Early Percutaneous Coronary Intervention. | Angiology | 2026 | https://conductscience.org/library/papers/40988347 | PubMed |
| 3 | 32408781 | Montelukast, a cysteinyl leukotriene receptor antagonist, exerts local antinociception in animal model of pain through the L-arginine/nitric oxide/cyclic GMP/KATP channel pathway and PPARγ receptors. | Int J Neurosci | 2021 | https://conductscience.org/library/papers/32408781 | PubMed |
| 4 | 21112334 | Inhibition of leukotriene C4 action reduces oxidative stress and apoptosis in cardiomyocytes and impedes remodeling after myocardial injury. | J Mol Cell Cardiol | 2011 | https://conductscience.org/library/papers/21112334 | PubMed |
| 5 | 11167954 | Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years. | Clin Exp Allergy | 2001 | https://conductscience.org/library/papers/11167954 | PubMed |
| 6 | 38337010 | Montelukast, an available and safe anti-asthmatic drug, prevents maladaptive remodelling and maintains cardiac functionality following myocardial infarction. | Sci Rep | 2024 | https://conductscience.org/library/papers/38337010 | PubMed |
| 7 | 32908939 | Immune and Inflammation in Acute Coronary Syndrome: Molecular Mechanisms and Therapeutic Implications. | J Immunol Res | 2020 | https://conductscience.org/library/papers/32908939 | PubMed |
| 8 | 33519477 | Montelukast Use Decreases Cardiovascular Events in Asthmatics. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33519477 | PubMed |
| 9 | 32109511 | Montelukast ameliorates Concanavalin A-induced autoimmune hepatitis in mice via inhibiting TNF-α/JNK signaling pathway. | Toxicol Appl Pharmacol | 2020 | https://conductscience.org/library/papers/32109511 | PubMed |
| 10 | 27432447 | The Role of Serum Bilirubin Levels in Predicting Troponin Positivity in Non-ST-Segment Elevation Acute Coronary Syndrome. | Angiology | 2017 | https://conductscience.org/library/papers/27432447 | PubMed |
| 11 | 36394077 | Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome. | Physiol Rep | 2022 | https://conductscience.org/library/papers/36394077 | PubMed |
| 12 | 17978293 | Leukotrienes. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17978293 | PubMed |
| 13 | 39073419 | Omega-3 fatty acids effectively mitigate high-sensitivity C-reactive protein (hs-CRP) biomarker of inflammation in acute myocardial infarction patients: a randomized, double-blind, placebo-controlled clinical trial. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39073419 | PubMed |
| 14 | 36145367 | Montelukast and Acute Coronary Syndrome: The Endowed Drug. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/36145367 | PubMed |
| 15 | 35399644 | Acetyl-11-Keto-β-Boswellic Acid (AKBA) Prevents Lipopolysaccharide-Induced Inflammation and Cytotoxicity on H9C2 Cells. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/35399644 | PubMed |
| 16 | 26089034 | Montelukast attenuates lipopolysaccharide-induced cardiac injury in rats. | Hum Exp Toxicol | 2016 | https://conductscience.org/library/papers/26089034 | PubMed |
| 17 | 17646220 | The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics. | Chest | 2007 | https://conductscience.org/library/papers/17646220 | PubMed |
| 18 | 21789470 | The effects of montelukast on antioxidant enzymes and proinflammatory cytokines on the heart, liver, lungs, and kidneys in a rat model of cecal ligation and puncture-induced sepsis. | ScientificWorldJournal | 2011 | https://conductscience.org/library/papers/21789470 | PubMed |
| 19 | 31685419 | The Pathophysiology of Myocardial Ischemia and Perioperative Myocardial Infarction. | J Cardiothorac Vasc Anesth | 2020 | https://conductscience.org/library/papers/31685419 | PubMed |
| 20 | 29890415 | Montelukast inhibits inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes. | Int Immunopharmacol | 2018 | https://conductscience.org/library/papers/29890415 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41870545
GET https://conductscience.org/api/papers/v1/41870545/references?page=2